Bioderecho.es, 2017 El objetivo de esta comunicación es dar cuenta de la última modificación de la regulación europea sobre Organismos Modificados Genéticamente (en adelante OMG), en lo que respecta a la posibilidad de que los Estados miembros restrinjan o prohíban el ...
Isabel Hernández San Juan
doaj
Case Report: Use of telitacicept for ocular myasthenia gravis. [PDF]
Front ImmunolYang A, Zhao J, Li F, Pang R, Zang W.
europepmc +1 more source
An introduction to OMG/CORBA (tutorial) [PDF]
Proceedings of the 19th international conference on Software engineering - ICSE '97, 1997 openaire +1 more source
Identification of Ocular and Systemic Predictors and Development of a Prediction Model in Ocular Myasthenia Gravis. [PDF]
Transl Vis Sci TechnolCai Y +5 more
europepmc +1 more source
Untargeted serum metabolomic profiling in patients with generalized and ocular myasthenia gravis. [PDF]
BMC OphthalmolWei B, Yuan H, He J, Hu Y, Li J, Wu X.
europepmc +1 more source
Enhancing the diagnostic yield of myasthenia gravis using 7-Hz repetitive nerve stimulation: an 11-year retrospective study. [PDF]
Clin Neurophysiol PractHsieh CC, Sun YT.
europepmc +1 more source
Early Relapse Frequency as a Potential Predictor of Generalization in Ocular Myasthenia Gravis: A Case Report. [PDF]
CureusTerai J +3 more
europepmc +1 more source
Wearable optomyography enables continuous neuroprosthetic control. [PDF]
Sci RepKhalikov R +3 more
europepmc +1 more source
Muscle myography for human-machine interfaces: a review of sensing modalities and control interfaces. [PDF]
Front Bioeng BiotechnolZhuwawu SS, Owen M, Bifet A, Dwivedi A.
europepmc +1 more source
Factors Influencing the Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Retrospective Cohort Study. [PDF]
J OphthalmolChuenkongkaew W +6 more
europepmc +1 more source